<DOC>
	<DOCNO>NCT01278498</DOCNO>
	<brief_summary>Through study , investigator demonstrate superiority Escitalopram placebo prevention poststroke depression patient acute stroke The primary hypothesis study ; This study prove superiority Escitalopram prevention poststroke depression patient acute stroke placebo</brief_summary>
	<brief_title>The Preventive Effect Escitalopram Depression Related Emotional Disorders Acute Stroke Patients</brief_title>
	<detailed_description>This study randomize stroke patient either SSRI , Lexacure tablet placebo investigate whether Lexacure effective prevent depression relate symptom 3 month drug administration . Patients acute stroke ( within 21 day onset ) enrol take study drug 5mg first week 10mg ( 2nd week ) 12 week . The first visit perform 4 week drug administration . Drug safety , depression relate symptom evaluate follow 12-week visit perform . In 13th week drug administration , study drug reduce 10mg every day one week , schedule drug administration complete . At 14th week , subject instructed take study drug assess maintenance effect . At 24th week , subject follow-up visit assess poststroke depression relate symptom . If subject discontinues study termination severe depression , aggressive intervention initiate 4th week , 12-week visit perform unless subject disagrees . If investigator judge patient severe depression 12-week visit , treat . All patient need treat depression follow 12th week .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Adults older 20 year Patients acute stroke ( ischemic stroke cerebral hemorrhage ) confirm neuroimaging within 21 day stroke onset Patients hemorrhagic transformation infarcted tissue include , investigator judge risk bleed small ( i.e. , reduced amount blood followup neuroimaging ) patient enrol . Patients MRS ≥ 2 screening Patients without definite history depression Patients fulfill follow criterion KMADRS test : The combine score 9th question ( pessimistic thought ) 10th question ( suicidal idea ) ≤ 7 The score 10th question &lt; 6 Patients without serious communication problem Patients agree participate trial Patients MRS 0 1 screening Patients definite history depression take antidepressant Patients diagnose bipolar disorder psychiatric disorder Patients severe dementia aphasia . However , motor aphasia still communicable enrolled Patients take migraine medication screening expect take migraine medication frequently due severe migraine Patients strong suicidal idea screen test express wish treat depression Patients consider treated depression charge physician Patients need SSRI medication reason Patients take antiepileptic drug screen Patients history traumatic brain injury , brain tumor , brain disease ( except stroke ) within 30 day prior screen Patients uncommon cause stroke ( e.g . subarachnoid hemorrhage , venous thrombosis , arteriovenous malformation , Moyamoya disease ) Patients bleed diathesis , hemophilia , thrombocytopenia Patients severe concomitant illness ( e.g . liver disease , renal disease , malignancy ) Patients abnormal blood test Abnormal LFT ( ALT &gt; 200 AST &gt; 200 ) Anemia ( Hb &lt; 8 mg/dl ) thrombocytopenia ( &lt; 100,000/mm3 ) Renal insufficiency ( Cr &gt; 3.0 mg/dl ) renal failure require dialysis Patients severe heart failure ( NYHA class III IV ) NYHA classification heart failure Class I : patient limitation activity ; suffer symptom Ordinary activity Class II : patient slight , mild limitation activity ; comfortable rest mild exertion Class III : patient marked limitation activity ; comfortable rest Class IV : patient complete rest , confine bed chair ; activity bring Pregnant lactate patient Patients participate another clinical trial , participate observational study enrol</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Escitalopram</keyword>
	<keyword>Depression</keyword>
	<keyword>Stroke</keyword>
</DOC>